- Home
- DT vs ZBH Comparison
DT vs ZBH Comparison
Compare DT & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DT
- ZBH
- Stock Information
- Founded
- DT 2005
- ZBH 1927
- Country
- DT United States
- ZBH United States
- Employees
- DT N/A
- ZBH N/A
- Industry
- DT Computer Software: Prepackaged Software
- ZBH Industrial Specialties
- Sector
- DT Technology
- ZBH Health Care
- Exchange
- DT Nasdaq
- ZBH Nasdaq
- Market Cap
- DT 16.3B
- ZBH 19.1B
- IPO Year
- DT 2019
- ZBH N/A
- Fundamental
- Price
- DT $48.28
- ZBH $102.81
- Analyst Decision
- DT Buy
- ZBH Hold
- Analyst Count
- DT 23
- ZBH 20
- Target Price
- DT $62.18
- ZBH $112.39
- AVG Volume (30 Days)
- DT 3.4M
- ZBH 1.8M
- Earning Date
- DT 08-06-2025
- ZBH 08-07-2025
- Dividend Yield
- DT N/A
- ZBH 0.93%
- EPS Growth
- DT 210.99
- ZBH N/A
- EPS
- DT 1.62
- ZBH 4.11
- Revenue
- DT $1,776,812,000.00
- ZBH $7,833,800,000.00
- Revenue This Year
- DT $18.80
- ZBH $7.64
- Revenue Next Year
- DT $14.57
- ZBH $5.64
- P/E Ratio
- DT $29.83
- ZBH $25.00
- Revenue Growth
- DT 18.70
- ZBH 4.11
- 52 Week Low
- DT $39.30
- ZBH $89.22
- 52 Week High
- DT $63.00
- ZBH $116.71
- Technical
- Relative Strength Index (RSI)
- DT 39.44
- ZBH 67.08
- Support Level
- DT $50.20
- ZBH $101.56
- Resistance Level
- DT $47.81
- ZBH $103.57
- Average True Range (ATR)
- DT 1.69
- ZBH 2.30
- MACD
- DT -0.32
- ZBH 0.97
- Stochastic Oscillator
- DT 25.75
- ZBH 94.63
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.